Ontario expands PCR testing and treatments for COVID-19. This is who's eligible
The Ontario government is making antiviral treatments and PCR testing for COVID-19 more widely available as the province grapples with an increase in infections and hospitalizations.
The new eligibility announced on Monday includes high-risk individuals who are immunocompromised and may be at higher risk of severe side effects after contracting COVID-19.
The following groups are now eligible for PCR testing and assessment for antiviral treatments such as Paxlovid:
- Individuals aged 18 and up who are immunocompromised
- Individuals aged 70 and up
- Individuals aged 60 and up with fewer than three vaccine doses
- Individuals aged 18 and up with fewer than three vaccine doses and at least one risk condition (For example, a chronic illness, heart disease, obesity, diabetes, ect.)
Individuals can take an online assessment to determine if they are eligible for the treatment.
The province is also allowing select pharmacies to dispense Paxlovid treatments with a prescription starting later this week. A full list of participating pharmacies will be available here at 8 a.m. on Wednesday.
The province said antiviral treatment must begin within five days of symptoms in most cases. A full course of treatment is three pills, twice daily, for five days in a row.
As such, individuals who are part of a higher risk group and who are experiencing symptoms should immediately seek testing and care through their health-care provider or at a clinical assessment centre.
“Antiviral treatment, including the oral antiviral Paxlovid can help to reduce hospitalizations, protect hospital capacity, and protect patients at high risk of severe health outcomes,” Ontario’s Chief Medical Officer of Health Dr. Kieran Moore said at a news conference held Monday. “Even if you don't have symptoms, talk to your primary care provider in advance to see if the treatment is right for you in the event that you get sick and have a plan.”
“Health-care providers can also determine if antiviral treatment is appropriate for patients based on individual circumstances even if they do not belong to one of the high risk groups.”
Patients can also use a positive rapid antigen test to be considered for antiviral treatment, officials said.
The province says they anticipate a regular supply of Paxlovid, an oral antiviral manufactured by Pfizer and approved by Health Canada earlier this year, throughout 2022.
Prior to today’s announcement, the drug was only available to a select group of people, including immunocompromised adults, unvaccinated people aged 60 and up, and unvaccinated people aged 50 and up if they are Indigenous or have one or more risk factors.
At his first news conference in nearly a month, Moore reiterated the importance of getting vaccinated. Ontario residents aged 60 and up are now being urged to book their fourth doses five months after receiving their third shot.
Moore is also recommending that people continue to wear masks amid Ontario's sixth wave of the pandemic.
CTVNews.ca Top Stories
NDP calls out Conservatives for effort to squash pharmacare legislation
The federal New Democrats are calling out Conservative Leader Pierre Poilievre and his party for trying to block the bill that could pave the way for millions of Canadians to access birth control and diabetes coverage.
Stamp prices rise for the third time in five years amid financial woes for Canada Post
Canada Post is increasing stamp prices for the third time since 2019, a move the Crown corporation says is a "reality" of its sales-based revenue structure.
Winnipeg man admits to killing four women, argues he's not criminally responsible
Defence lawyers of Jeremy Skibicki have admitted in court the accused killed four Indigenous women, but argues he is not criminally responsible for the deaths by way of mental disorder – this latest development has triggered a judge-alone trial rather than a jury trial.
An El Nino-less summer is coming. Here's what that could mean for Canada
As Canadians brace themselves for summer temperatures, forecasters say a weakening El Nino cycle doesn’t mean relief from the heat.
Mediterranean staple may lower your risk of death from dementia, study finds
A daily spoonful of olive oil could lower your risk of dying from dementia, according to a new study by Harvard scientists.
A subset of Alzheimer's cases may be caused by two copies of a single gene, new research shows
For the first time, researchers have identified a genetic form of late-in-life Alzheimer’s disease — in people who inherit two copies of a worrisome gene.
Ontario MPP asked again to leave Ontario legislature over keffiyeh, Speaker loosens ban
An Ontario MPP was asked again to leave the Ontario legislature on Monday for wearing a keffiyeh, a garment that was banned by the Speaker last month due to its political symbolism.
WATCH Avian flu: Risk to humans grows as outbreaks spread, warns expert
H5N1 or avian flu is decimating wildlife around the world and is now spreading among cattle in the United States, sparking concerns about 'pandemic potential' for humans. Now a health expert is urging Canada to scale up surveillance north of the border.
Trudeau Liberals to unveil new bill Monday aimed at countering foreign interference
Democratic Institutions Minister Dominic LeBlanc will be tabling legislation on Monday aimed at countering foreign interference in Canada. Federal officials have scheduled a technical briefing on the incoming bill for Monday afternoon.